We're obsessed with death as an endpoint because it's easy to track. A heart stops, and we’ve got a clean data point. But the real biology of aging happens at the Kinetic Deflection—that specific moment a physiological system stops bouncing back and starts sliding into chronic, managed failure.

Current longevity trials are too focused on survival curves. If we add five years to a life but those years are spent in the Morbidity Shadow, propped up by a dozen different prescriptions, we haven't solved aging. We’ve just subsidized a longer decline. It doesn't make sense to use death as our primary metric when the real civilizational crisis is the duration of the decay.

I’m looking for collaborators for the First-Failure Mapping Project (FFMP). Our team is working on the hypothesis that there’s a detectable Proteostatic Pre-Threshold—a molecular signature that shows up three to five years before the first clinical diagnosis of an age-related disease. By the time a patient shows signs of insulin resistance or cognitive impairment, the longevity signal is already drowned out by noise. We’re trying to quantify the Compression Ratio: the delta between that first morbidity and death.

We need PIs specializing in high-resolution longitudinal proteomics and metabolic flux analysis to join a multi-center consortium. We have to move past Kaplan-Meier and fund the identification of the Deflection Point, not just the cemetery gate.

Think about two 95-year-olds. One dies after a three-day bout of pneumonia; the other survived twenty years on a cocktail of drugs. They aren't biologically the same. One represents a failure of robustness, while the other is a triumph of engineering over a collapsing foundation. Our data sets shouldn't treat them like equals.

We’ve secured seed funding for a 500-subject pilot using continuous multi-omic monitoring. Now we need analytical partners to help us build a new metric for "Biological Velocity." If you're tired of the "Death as Endpoint" dogma and want to build the toolkit for true healthspan compression, let’s talk. The signal is in the onset, not the end.